Contact UsInvestorsCareersMediaScienceContact Us
Home Science

Areas of Focus


The science of optimism

View All Oncology

Preventing the spread of infections

View All Vaccines
Anti Infectives

Combatting an evolving risk

View All Anti Infectives
Inflammation & Immunology

Treatment at the molecular level

View All Inflammation & Immunology
Rare Disease

Smaller populations but big impact 

View All Rare Disease
Learn More

China Research & Development Center

Pfizer China R&D Center (CRDC) is an important R&D hub of Pfizer in the world and the Asia Pacific region. It provides comprehensive support services for the development projects of the global product line. Over the past more than 30 years, Pfizer has introduced over 70 innovative products to China, including original drugs and vaccines. By 2025, Pfizer plans to achieve 24 breakthrough innovative products to apply for listing, and with the gradual implementation of the strategic goal of "80%&80%, we will try our best to realize the simultaneous application of product research and development in China to meet the health needs of Chinese patients at all stages of life.


Pfizer China R&D Center was established on October 31, 2005, at Shanghai Zhangjiang High-tech Park Zone. It is one of the earliest and largest R & D centers set up by multinational pharmaceutical enterprises in China.


In 2010, Pfizer China R&D center Wuhan Branch was established, located in Wuhan Biolake Science and Technology Industrial Park.

Pipeline Publicity of Medical RepresentativesPfizer Medical Information PfizerPro for Professionals Grant Seekers Media Terms of UseContact Us Business to Business © 2022 Pfizer Inc. All rights reserved 沪公网安备31010602006040 沪ICP备11000910号-2 药监批号(沪)-非经营性-2016-0003